Cannonau Corp. (OTCPK: CNNC)
Health Care · Pharmaceuticals · US
$0.00
-33.33% today · +100.0% 1Y
Cannonau Corp. (OTCPK: CNNC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $48.36K and employs 4 people.
Over the last twelve months the share price has gained 100.0%, trading between 0.00 and 0.04.
Tweenvest scores Cannonau Corp. across four factors: quality 14/100. Its strongest factor is quality.
CNNC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $48.36K
- Revenue (TTM)
- —
- P/E
- 0.14
- EPS
- 0.00
- Dividend yield
- —
- Beta (5Y)
- 2.10
- 52-week high
- $0.04
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 241.82M
- Employees
- 4
- Next earnings
- —
About Cannonau Corp.
Cannonau Corp. specializes in the development and marketing of products based on cannabidiol. The company, which was established in 2007, previously operated as Pacific Blue Energy Corp. before officially rebranding to Cannonau Corp. in August 2019. Its operations are headquartered in Skaneateles, New York.
- ISIN
- US13767L1098
- Founded
- 2007
- Listed since
- Mar 12, 2010
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.00 | +0.13% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.16 | +0.34% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.18 | -0.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.30 | -1.41% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.00 | -1.14% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.23% |
Figures last refreshed Aug 18, 2026.